株探米国株
日本語 英語
エドガーで原本を確認する
false000070754900007075492023-01-232023-01-23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 23, 2023
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware   0-12933   94-2634797
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share LRCX The Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      ☐


Table of Contents
 
Item 2.02.    Results of Operations and Financial Condition  
Item 2.05. Costs Associated with Exit or Disposal Activities
Item 9.01.    Financial Statements and Exhibits  
SIGNATURES  
EX-99.1


 Item 2.02. Results of Operations and Financial Condition
On January 25, 2023, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended December 25, 2022, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 2.05. Costs Associated with Exit or Disposal Activities
On January 23, 2023, the Company commenced a workforce reduction that is intended to better align the Company’s cost structure with its outlook for the current economic environment and future business opportunities (the “Restructuring Plan”). The Company expects the Restructuring Plan to entail a workforce reduction of approximately 1,300 employee positions, which is approximately 7% of the Company’s total number of employees. This Restructuring Plan is expected to be substantially completed by the end of the quarter ending June 25, 2023, but the timing of actions may vary by country based on local legal requirements.

The Restructuring Plan is expected to result in total charges of approximately $80.0 million, to be incurred during the quarter ending March 26, 2023. These charges are expected to consist of cash charges related to one-time termination benefits associated with the workforce reduction.

The Company anticipates implementing further cost reduction activities over the next twelve months that are not part of the Restructuring Plan, some of which may result in additional expenditures and charges in future quarters.

Caution Regarding Forward-Looking Statements
Statements made in this report on Form 8-K that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to the expected nature, cost, timing, and scope of the Restructuring Plan and future cost reduction activities. Some factors that may affect these forward-looking statements include: the risk that the restructuring charges may be greater than anticipated; the risk that the Company’s restructuring efforts may adversely affect the Company’s internal programs and the Company’s ability to recruit and retain skilled and motivated personnel, and may be distracting to employees and management; the risk that the Company’s restructuring efforts may negatively impact the Company’s business operations and reputation with or ability to serve customers; the risk that the Company’s restructuring efforts may not generate their intended benefits to the extent or as quickly as anticipated; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 26, 2022 and our quarterly report on Form 10-Q for the quarter ended September 25, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this Form 8-K.
 Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 25, 2023
LAM RESEARCH CORPORATION
(Registrant)
  /s/ Douglas R. Bettinger
  Douglas R. Bettinger
  Executive Vice President, Chief Financial Officer
  (Principal Financial Officer and Principal Accounting Officer)
 


EX-99.1 2 lrcx_exhibitx991xq2x2023.htm EX-99.1 Document

Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended December 25, 2022
FREMONT, Calif., January 25, 2023 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 25, 2022 (the “December 2022 quarter”).
Highlights for the December 2022 quarter were as follows:
•Revenue of $5.28 billion.
•U.S. GAAP gross margin of 45.0%, U.S. GAAP operating income as a percentage of revenue of 31.8%, and U.S. GAAP diluted EPS of $10.77.
•Non-GAAP gross margin of 45.1%, non-GAAP operating income as a percentage of revenue of 32.1%, and non-GAAP diluted EPS of $10.71.
Key Financial Data for the Quarters Ended
December 25, 2022 and September 25, 2022
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
  December 2022 September 2022 Change Q/Q
Revenue $ 5,277,569  $ 5,074,121  + 4%
Gross margin as percentage of revenue 45.0  % 46.1  % - 110 bps
Operating income as percentage of revenue 31.8  % 33.5  % - 170 bps
Diluted EPS $ 10.77  $ 10.39  + 3.7%
Non-GAAP
  December 2022 September 2022 Change Q/Q
Revenue $ 5,277,569  $ 5,074,121  + 4%
Gross margin as percentage of revenue 45.1  %   46.0  % - 90 bps
Operating income as percentage of revenue 32.1  %   33.3  % - 120 bps
Diluted EPS $ 10.71    $ 10.42  + 2.8%

U.S. GAAP Financial Results
For the December 2022 quarter, revenue was $5,278 million, gross margin was $2,376 million, or 45.0% of revenue, operating expenses were $696 million, operating income was 31.8% of revenue, and net income was $1,469 million, or $10.77 per diluted share on a U.S. GAAP basis. This compares to revenue of $5,074 million, gross margin of $2,337 million, or 46.1% of revenue, operating expenses of $639 million, operating income of 33.5% of revenue, and net income of $1,426 million, or $10.39 per diluted share, for the quarter ended September 25, 2022 (the “September 2022 quarter”).
Non-GAAP Financial Results
For the December 2022 quarter, non-GAAP gross margin was $2,382 million, or 45.1% of revenue, non-GAAP operating expenses were $686 million, non-GAAP operating income was 32.1% of revenue, and non-GAAP net income was $1,461 million, or $10.71 per diluted share. This compares to non-GAAP gross margin of $2,335 million, or 46.0% of revenue, non-GAAP operating expenses of $647 million, non-GAAP operating income of 33.3% of revenue, and non-GAAP net income of $1,429 million, or $10.42 per diluted share, for the September 2022 quarter.

“Lam closed out 2022 with record revenue and earnings per share for both the December quarter and calendar year, despite supply chain challenges and inflationary pressures,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “Given the decline in wafer fabrication equipment spending expected in calendar year 2023, we are taking proactive steps to lower our cost structure and drive efficiencies across our global footprint, while preserving critical R&D. With these actions, Lam is focused on accelerating our strategic priorities to capitalize on the semiconductor industry’s long-term growth prospects.”






Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to $4.8 billion at the end of the December 2022 quarter compared to $4.6 billion at the end of the September 2022 quarter. This increase was primarily the result of $1,140 million of cash generated from operating activities, partially offset by $456 million of share repurchases, including net share settlement of employee stock-based compensation; $236 million of dividends paid to stockholders; and $163 million of capital expenditures.
Deferred revenue at the end of the December 2022 quarter decreased to $1,984 million compared to $2,755 million as of the end of the September 2022 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $379 million as of December 25, 2022 and $401 million as of September 25, 2022.
Revenue
The geographic distribution of revenue during the December 2022 quarter is shown in the following table:
Region Revenue
China 24%
Korea 20%
Taiwan 19%
Japan 11%
Southeast Asia 10%
United States 10%
Europe 6%
The following table presents revenue disaggregated between system and customer support-related revenue:
Three Months Ended
December 25,
2022
September 25,
2022
December 26,
2021
(In thousands)
System revenue $ 3,547,518  $ 3,181,987  $ 2,740,173 
Customer support-related revenue and other 1,730,051  1,892,134  1,486,431 
$ 5,277,569  $ 5,074,121  $ 4,226,604 
System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook

For the quarter ended March 26, 2023, Lam is providing the following guidance:

U.S. GAAP Reconciling Items Non-GAAP
Revenue $3.8 Billion +/- $300 Million $3.8 Billion +/- $300 Million
Gross margin as a percentage of revenue 42.8% +/- 1% $ 45  Million 44.0% +/- 1%
Operating income as a percentage of revenue 25.3% +/- 1% $ 84  Million 27.5% +/- 1%
Net income per diluted share $5.95 +/- $0.75 $ 74  Million $6.50 +/- $0.75
Diluted share count 135 million 135 million
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:




•Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3 million; and restructuring charges, $42 million; totaling $45 million.

•Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $4 million; and restructuring charges, $80 million; totaling $84 million.

•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $4 million; restructuring charges; $80 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($11 million); totaling $74 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the December 2022 and September 2022 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. Additionally, the non-GAAP results for the December 2022 quarter excludes a net income tax benefit associated with legal entity restructuring.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our expectations for wafer fabrication equipment spending; our cost structure and steps we are taking to lower it and drive efficiencies; our ability to preserve research and development; our ability to accelerate our strategic priorities; and the semiconductor industry’s long-term growth prospects and our ability to capitalize on them. Some factors that may affect these forward-looking statements include: trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 26, 2022 and our quarterly report on Form 10-Q for the fiscal quarter ended September 25, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)
Consolidated Financial Tables Follow.
 ###





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited) 
  Three Months Ended Six Months Ended
  December 25,
2022
September 25,
2022
December 26,
2021
December 25,
2022
December 26,
2021
Revenue $ 5,277,569  $ 5,074,121  $ 4,226,604  $ 10,351,690  $ 8,531,069 
Cost of goods sold 2,901,220  2,737,286  2,248,688  5,638,506  4,576,399 
Gross margin 2,376,349  2,336,835  1,977,916  4,713,184  3,954,670 
Gross margin as a percent of revenue 45.0  % 46.1  % 46.8  % 45.5  % 46.4  %
Research and development 462,385  433,375  403,644  895,760  785,971 
Selling, general and administrative 233,802  205,620  236,133  439,422  458,327 
Total operating expenses 696,187  638,995  639,777  1,335,182  1,244,298 
Operating income 1,680,162  1,697,840  1,338,139  3,378,002  2,710,372 
Operating income as a percent of revenue 31.8  % 33.5  % 31.7  % 32.6  % 31.8  %
Other income (expense), net (28,234) (43,095) 17,999  (71,329) (10,858)
Income before income taxes 1,651,928  1,654,745  1,356,138  3,306,673  2,699,514 
Income tax expense (183,421) (228,866) (161,308) (412,287) (324,940)
Net income $ 1,468,507  $ 1,425,879  $ 1,194,830  $ 2,894,386  $ 2,374,574 
Net income per share:
Basic $ 10.80  $ 10.42  $ 8.50  $ 21.21  $ 16.82 
Diluted $ 10.77  $ 10.39  $ 8.44  $ 21.16  $ 16.71 
Number of shares used in per share calculations:
Basic 136,018  136,891  140,630  136,455  141,187 
Diluted 136,339  137,208  141,530  136,774  142,071 
Cash dividend declared per common share $ 1.725  $ 1.725  $ 1.50  $ 3.450  $ 3.00 
 















 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
December 25,
2022
September 25,
2022
June 26,
2022
(unaudited) (unaudited) (1)
ASSETS
Cash and cash equivalents $ 4,484,716  $ 4,256,499  $ 3,522,001 
Investments 103,130  120,551  135,731 
Accounts receivable, net 4,070,088  4,569,735  4,313,818 
Inventories 4,819,966  4,360,325  3,966,294 
Prepaid expenses and other current assets 230,888  305,554  347,391 
Total current assets 13,708,788  13,612,664  12,285,235 
Property and equipment, net 1,863,155  1,718,791  1,647,587 
Restricted cash and investments 251,344  250,955  251,534 
Goodwill and intangible assets 1,805,218  1,624,932  1,616,963 
Other assets 1,577,876  1,513,940  1,394,313 
Total assets $ 19,206,381  $ 18,721,282  $ 17,195,632 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations $ 7,226  $ 7,110  $ 7,381 
Other current liabilities 4,539,696  5,046,272  4,557,378 
Total current liabilities 4,546,922  5,053,382  4,564,759 
Long-term debt and finance lease obligations 4,996,057  4,996,363  4,998,449 
Income taxes payable 862,405  840,214  931,117 
Other long-term liabilities 496,362  418,756  422,941 
Total liabilities 10,901,746  11,308,715  10,917,266 
Stockholders’ equity (2) 8,304,635  7,412,567  6,278,366 
Total liabilities and stockholders’ equity $ 19,206,381  $ 18,721,282  $ 17,195,632 
 
(1) Derived from audited financial statements.
(2)
Common shares issued and outstanding were 135,403 as of December 25, 2022, 136,374 as of September 25, 2022, and 136,975 as of June 26, 2022.
 





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
  Three Months Ended Six Months Ended
  December 25,
2022
September 25,
2022
December 26,
2021
December 25,
2022
December 26,
2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 1,468,507  $ 1,425,879  $ 1,194,830  $ 2,894,386  $ 2,374,574 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 85,414  75,751  81,705  161,165  161,579 
Deferred income taxes (6,680) (133,616) (13,550) (140,296) (26,573)
Equity-based compensation expense 73,084  71,110  62,834  144,194  120,933 
Other, net 12,729  (2,751) (66,514) 9,978  (75,204)
Changes in operating assets and liabilities (492,867) (246,785) 181,201  (739,652) (657,279)
Net cash provided by operating activities 1,140,187  1,189,588  1,440,506  2,329,775  1,898,030 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets (163,378) (140,063) (138,493) (303,441) (274,920)
Business acquisitions, net of cash acquired (119,955) —  —  (119,955) — 
Net maturities and sales of available-for-sale securities 17,743  14,695  325,171  32,438  1,063,214 
Other, net (1,657) (2,435) (595) (4,092) (5,518)
Net cash (used for) provided by investing activities (267,247) (127,803) 186,083  (395,050) 782,776 
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt (17,082) (1,854) (1,698) (18,936) (8,036)
Treasury stock purchases (456,276) (109,779) (414,815) (566,055) (1,651,568)
Dividends paid (235,980) (205,615) (211,216) (441,595) (396,647)
Reissuance of treasury stock related to employee stock purchase plan 44,996  —  46,380  44,996  46,380 
Proceeds from issuance of common stock 877  6,796  3,451  7,673  4,193 
Other, net 1,253  (489) (205) 764  (17)
Net cash used for financing activities (662,212) (310,941) (578,103) (973,153) (2,005,695)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 17,878  (16,925) (4,678) 953  (8,454)
Net increase in cash, cash equivalents, and restricted cash 228,606  733,919  1,043,808  962,525  666,657 
Cash, cash equivalents, and restricted cash at beginning of period 4,507,454  3,773,535  4,293,599  3,773,535  4,670,750 
Cash, cash equivalents, and restricted cash at end of period $ 4,736,060  $ 4,507,454  $ 5,337,407  $ 4,736,060  $ 5,337,407 




 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
December 25,
2022
September 25,
2022
Revenue $ 5,277,569  $ 5,074,121 
Gross margin $ 2,381,723  $ 2,335,168 
Gross margin as percentage of revenue 45.1  % 46.0  %
Operating expenses $ 686,348  $ 647,239 
Operating income $ 1,695,375  $ 1,687,929 
Operating income as a percentage of revenue 32.1  % 33.3  %
Net income $ 1,460,575  $ 1,429,495 
Net income per diluted share $ 10.71  $ 10.42 
Shares used in per share calculation - diluted 136,339  137,208 
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
December 25,
2022
September 25,
2022
U.S. GAAP net income $ 1,468,507  $ 1,425,879 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 2,521  1,451 
Elective deferred compensation ("EDC") related liability valuation increase (decrease) - cost of goods sold 2,853  (3,118)
EDC related liability valuation increase (decrease) - research and development 5,136  (5,612)
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 1,279  1,110 
EDC related liability valuation increase (decrease) - selling, general and administrative 3,424  (3,742)
Amortization of note discounts - other income (expense), net 712  707 
(Gain) loss on EDC related asset - other income (expense), net (10,871) 12,726 
Net income tax (benefit) expense on non-GAAP items (1,213) 94 
Net income tax benefit associated with legal entity restructuring (11,773) — 
Non-GAAP net income $ 1,460,575  $ 1,429,495 
Non-GAAP net income per diluted share $ 10.71  $ 10.42 
U.S. GAAP net income per diluted share $ 10.77  $ 10.39 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 136,339  137,208 




 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
Three Months Ended
December 25,
2022
September 25,
2022
U.S. GAAP gross margin $ 2,376,349  $ 2,336,835 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 2,521  1,451 
EDC related liability valuation increase (decrease) 2,853  (3,118)
Non-GAAP gross margin $ 2,381,723  $ 2,335,168 
U.S. GAAP gross margin as a percentage of revenue 45.0  % 46.1  %
Non-GAAP gross margin as a percentage of revenue 45.1  % 46.0  %
U.S. GAAP operating expenses $ 696,187  $ 638,995 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations (1,279) (1,110)
EDC related liability valuation (increase) decrease (8,560) 9,354 
Non-GAAP operating expenses $ 686,348  $ 647,239 
U.S. GAAP operating income $ 1,680,162  $ 1,697,840 
Non-GAAP operating income $ 1,695,375  $ 1,687,929 
U.S. GAAP operating income as percent of revenue 31.8  % 33.5  %
Non-GAAP operating income as a percent of revenue 32.1  % 33.3  %
 
Lam Research Corporation Contacts:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com